| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |